[A study on the active efflux system in methicillin-resistant Staphylococcus aureus]

Xiao-lan Gao1, Bao Liu, Kui Jin

  • 1Intensive Care Unit, Anhui Province Hospital, Affiliated to Anhui Medical University, Hefei 230032, Anhui, China.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) infections are a serious concern in intensive care units (ICUs). This study found that MRSA is multi-drug resistant and possesses active efflux genes, which can be inhibited by omeprazole.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Context:

  • Intensive care units (ICUs) are high-risk environments for healthcare-associated infections.
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen contributing to ICU morbidity and mortality.
  • Understanding the mechanisms of antibiotic resistance in MRSA is crucial for effective treatment strategies.

Purpose:

  • To determine the prevalence of MRSA in an ICU setting.
  • To investigate the genetic basis of active efflux mechanisms in clinical MRSA isolates.
  • To evaluate the potential of omeprazole in overcoming MRSA antibiotic resistance.

Summary:

  • A high detection rate of MRSA (78.4%) was observed in the ICU.
  • The study identified the presence of active efflux genes (norA, qacA, qacB, and qacJ) in MRSA isolates.
  • Omeprazole demonstrated the ability to inhibit these efflux genes and reduce the minimal inhibitory concentration (MIC) of certain antibiotics, like levofloxacin.

Impact:

  • The findings highlight the critical issue of MRSA infections and multi-drug resistance in ICUs.
  • Identifying active efflux genes provides insight into MRSA's resistance mechanisms.
  • Omeprazole shows promise as an adjuvant therapy to enhance antibiotic efficacy against resistant MRSA strains.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...